Dieter Gericke

Practice Areas

Dieter Gericke heads the Corporate / M&A practice team. He focuses on public and private M&A, shareholder activism, equity capital markets (incl. IPOs), private equity and corporate governance.

Career

Head of Corporate / M&A team since 2014, Co-Head of Healthcare/Life Sciences, Head of China Group since 2010, Partner since 2004, joined Homburger in 2000. Foreign associate Wilmer Hale, Boston, 1999. Associate at Zurich law firm 1996-98. Legal assistant University of Zurich 1994-95. Law clerk Court of Meilen 1991-93.

Professional Memberships

Zurich Bar Association, IBA (Corporate / M&A Law Committee, Securities Law Committee).

Publications

Various publications and speaking assignments in M&A, equity capital markets, private equity and corporate law.

Personal

Harvard 1999 (LLM); University of Zurich) (Dr iur, summa cum laude, 1996); 1991 (lic iur, S.C.L., 1991).

Université de Paris II (Assas)

Work Highlights

Recent assignments include advising SoftwareOne in the unsolicited approach by Bain Capital, Tencent on its investments in Global Blue, Bobst Group in the take private by JBF Finance, CSL in the public takeover of Vifor Pharma, ChemChina in the public takeover of Syngenta, EF in the sale of its China kids business, Therachon in the sale to Pfizer, Meyer Burger in a proxy fight and capital increase, KKR in the acquisition of Biosynth, Bühler in the acquisition of Haas Group, Givaudan in the acquisition of Induchem, Infront Sports & Media in the sale to Dalian Wanda or Nestlé in the sale of Alcon to Novartis.